FLRT3



FLRT3

K1KK1S2SS2C3CC3P4PP4S5SS5V6VV6C7CC7R8RR8C9CC9D10DD10A11AA11G12GG12F13FF13I14II14Y15YY15C16CC16N17NN17D18DD18R19RR19S20SS20L21LL21T22TT22S23SS23I24II24P25PP25V26VV26G27GG27I28II28P29PP29E30EE30D31DD31A32AA32T33TT33T34TT34L35LL35Y36YY36L37LL37Q38QQ38N39NN39N40NN40Q41QQ41I42II42N43NN43N44NN44V45VV45G46GG46I47II47... and 574 more residue(s)...... and 574 more residue(s)

SMILES None
InChIKey None
Sequence KSCPSVCRCDAGFIYCNDRSLTSIPVGIPEDATTLYLQNNQINNVGIPSDLKNLLKVQRIYLYHNSLDEFPTNLPKYVKELHLQENNIRTITYDSLSKIPYLEELHLDDNSVSAVSIEEGAFRDSNYLRLLFLSRNHLSTIPGGLPRTIEELRLDDNRISTISSPSLHGLTSLKRLVLDGNLLNNHGLGDKVFFNLVNLTELSLVRNSLTAAPVNLPGTSLRKLYLQDNHINRVPPNAFSYLRQLYRLDMSNNNLSNLPQGIFDDLDNITQLILRNNPWYCGCKMKWVRDWLQSLPVKVNVRGLMCQAPEKVRGMAIKDLSAELFDCKDSGIVSTVQITTAIPNTAYPAQGQWPAPVTKQPDIKNPKLTKDQRTTGSPSRKTILITVKSVTPDTIHISWRLALPMTALRLSWLKLGHSPAFGSITETIVTGERSEYLVTALEPESPYRVCMVPMETSNLYLFDETPVCIETQTAPLRMYNPTTTLNREQEKEPYKNPNLPLAAIIGGAVALVSIALLALVCWYVHRNGSLFSRNCAYSKGRRRKDDYAEAGTKKDNSILEIRETSFQMLPISNEPISKEEFVIHTIFPPNGMNLYKNNLSESSSNRSYRDSGIPDLDHSHS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

FLRT3

K1KK1S2SS2C3CC3P4PP4S5SS5V6VV6C7CC7R8RR8C9CC9D10DD10A11AA11G12GG12F13FF13I14II14Y15YY15C16CC16N17NN17D18DD18R19RR19S20SS20L21LL21T22TT22S23SS23I24II24P25PP25V26VV26G27GG27I28II28P29PP29E30EE30D31DD31A32AA32T33TT33T34TT34L35LL35Y36YY36L37LL37Q38QQ38N39NN39N40NN40Q41QQ41I42II42N43NN43N44NN44V45VV45G46GG46I47II47... and 574 more residue(s)...... and 574 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.